Li Malmberg
Nessuna posizione attualmente
Profilo
Li Malmberg is a professional who has held several positions in the biotechnology industry.
She was the Director & Head-Process Sciences at AbbVie, Inc., the VP-Biologics Development & Manufacturing at Celgene Corp., the Chief Technology & Manufacturing Officer at Xilio Therapeutics, Inc., and the Senior Vice President-CMC at Magenta Therapeutics, Inc. Malmberg received her undergraduate degree from the University of Illinois and her doctorate from the University of Minnesota Twin Cities.
Precedenti posizioni note di Li Malmberg
Società | Posizione | Fine |
---|---|---|
CELGENE | Corporate Officer/Principal | - |
XILIO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
ABBVIE INC. | Corporate Officer/Principal | - |
MAGENTA THERAPEUTICS | Corporate Officer/Principal | - |
Formazione di Li Malmberg
University of Minnesota Twin Cities | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
XILIO THERAPEUTICS, INC. | Health Technology |
ABBVIE INC. | Health Technology |
Aziende private | 2 |
---|---|
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Li Malmberg